You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 10,456,381


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,456,381
Title:Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of plasma cells and/or B-cells, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
Inventor(s): Bozik; Michael E. (Pittsburgh, PA), Dworetzky; Steven (Jefferson Hills, PA)
Assignee: Knopp Biosciences LLC (Pittsburgh, PA)
Application Number:16/013,071
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Claims and Patent Landscape of US Patent 10,456,381

Introduction

When analyzing a patent, particularly one like US Patent 10,456,381, it is crucial to delve into the specifics of the claims, the broader patent landscape, and the implications of recent developments in patent law and technology. This article will provide a comprehensive and critical analysis of these aspects.

The Importance of Patent Claims

Patent claims are the heart of any patent application, as they define the scope of the invention and the rights granted to the patent holder. The business and legal value of a patent resides primarily in its claims, which must be carefully crafted to ensure they are both valid and enforceable[2].

Overview of US Patent 10,456,381

To begin, one must identify the specific invention and claims outlined in US Patent 10,456,381. This involves reviewing the patent's abstract, description, and most importantly, the claims section. Each claim must be analyzed for its scope, novelty, and non-obviousness.

Claim Analysis

Independent and Dependent Claims

Independent claims stand alone and define the invention without reference to other claims. Dependent claims, on the other hand, refer back to and further limit the independent claims. The hierarchy of claims is crucial for understanding the full scope of the patent[2].

Claim Construction

The construction of claims is a critical step in patent analysis. This involves interpreting the language of the claims to determine their meaning and scope. Recent legal precedents, such as the case of Festo Corporation v. Shoketsu Kinzoku Kogyo Kabushiki Co. Ltd., have significant implications for claim construction, particularly regarding narrowing amendments and the doctrine of equivalents[2].

Patent Landscape and Prior Art

Patentability Search

A thorough patentability search is essential to determine if the claims of US Patent 10,456,381 are novel and non-obvious over the prior art. This search involves reviewing global patent publications and non-patent literature to identify any references that disclose similar inventions. Such searches help in revising claims to improve patentability[4].

Knock-out Patentability Search

This type of search compares the key features of the invention to relevant prior art, evaluating the strength of the invention and determining if claims need revision. It is a critical step in ensuring that the patent is robust and less likely to face validity challenges[4].

The Role of AI in Patent Applications

Disclosure Requirements

With the increasing use of AI tools in drafting patent applications, it is important to note that any material contributions made by AI must be disclosed to the USPTO. This includes situations where AI introduces alternative embodiments not conceived by the inventors. Ensuring compliance with these guidelines is crucial to maintaining the validity of the patent[3].

Accuracy and Verification

Practitioners must verify the accuracy of all factual assertions and legal statements in documents prepared with AI assistance. This ensures that no inaccurate statements or material omissions are introduced into the record, which could jeopardize the patent's validity[3].

Patent Prosecution and Allowance Rates

Historical Context

The allowance rate for patent applications at the USPTO has decreased over time, particularly in fields like Drugs and Medical Instruments and Computers and Communications. Only about 55.8% of patent applications filed between 1996 and mid-2013 were granted without using continuation procedures[1].

Current Trends

The increasing complexity and number of patent applications, along with the growing use of technology in the application process, have made the patent landscape more challenging. Automated tools and systems, such as the Patent Matrix software, are being developed to help manage and analyze large volumes of patent data[2].

Obviousness-Type Double Patenting (ODP)

Legal Implications

ODP analysis is critical in ensuring that multiple patents claiming the same invention or obvious variations thereof are not granted. Recent cases, such as In re Cellect, highlight the importance of performing ODP analysis to avoid invalidating patents within the same family[5].

Patent Term Adjustment (PTA) and Patent Term Extension (PTE)

Impact on Patent Validity

Patent Term Adjustment and Patent Term Extension can significantly affect the validity and enforceability of patents. Understanding these adjustments and how they interact with ODP is essential for maintaining the integrity of the patent portfolio[5].

Practical Considerations for Patent Holders

Monitoring and Enforcement

Patent holders must continuously monitor their patents and the broader patent landscape to defend against infringement and validity challenges. Comprehensive prior art searches and regular reviews of patent claims are essential for maintaining a strong patent position[4].

Licensing and M&A Due Diligence

When entering into licensing agreements or considering mergers and acquisitions, it is crucial to strength-test patents through thorough validity searches. This ensures that the patents in question are robust and can withstand legal scrutiny[4].

Key Takeaways

  • Claim Construction: Carefully interpret the language of claims to determine their scope and validity.
  • Prior Art Search: Conduct thorough searches to ensure novelty and non-obviousness over prior art.
  • AI Disclosure: Disclose any material contributions made by AI tools in the patent application process.
  • Patent Prosecution: Be aware of the decreasing allowance rates and increasing complexity in patent applications.
  • ODP Analysis: Perform ODP analysis to avoid invalidating patents within the same family.
  • PTA and PTE: Understand the impact of Patent Term Adjustment and Patent Term Extension on patent validity.

FAQs

  1. What is the significance of independent and dependent claims in a patent? Independent claims define the invention without reference to other claims, while dependent claims further limit the independent claims, providing a hierarchical structure to the patent.

  2. How does AI impact the patent application process? AI can assist in drafting patent applications, but any material contributions made by AI must be disclosed to the USPTO to ensure compliance with patent laws.

  3. What is the purpose of a patentability search? A patentability search identifies references that disclose the same or similar inventions, helping to determine if claims should be revised to improve patentability.

  4. Why is ODP analysis important? ODP analysis prevents the granting of multiple patents claiming the same invention or obvious variations, ensuring the validity of patents within the same family.

  5. How do Patent Term Adjustment and Patent Term Extension affect patent validity? These adjustments can impact the enforceability and validity of patents, particularly in cases where multiple patents claim priority from the same application.

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. US20110138338A1 - Patent Claims Analysis System and Method. Google Patents.
  3. U.S. Patent Office Issues Additional Guidance on Use of AI Tools. Buchanan Ingersoll & Rooney PC.
  4. Patent Search Services - Patent Validity Search. Clarivate.
  5. In re Cellect. United States Court of Appeals for the Federal Circuit.

More… ↓

⤷  Subscribe

Details for Patent 10,456,381

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Janssen Biotech, Inc. REMICADE infliximab For Injection 103772 August 24, 1998 ⤷  Subscribe 2033-08-13
Immunex Corporation ENBREL etanercept For Injection 103795 November 02, 1998 ⤷  Subscribe 2033-08-13
Immunex Corporation ENBREL etanercept For Injection 103795 May 27, 1999 ⤷  Subscribe 2033-08-13
Immunex Corporation ENBREL etanercept Injection 103795 September 27, 2004 ⤷  Subscribe 2033-08-13
Immunex Corporation ENBREL etanercept Injection 103795 February 01, 2007 ⤷  Subscribe 2033-08-13
Immunex Corporation ENBREL MINI etanercept Injection 103795 September 14, 2017 ⤷  Subscribe 2033-08-13
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.